Tove Cecilie Viebe
Founder & CEO
MD, Executive Master of Management, BI Norwegian Business School
Viebe is the founder and CEO of SEALD. She is a specialist in general surgery focusing on gastrointestinal surgery. Viebe holds an MBA from BI Norwegian Business School and is a former senior consultant at the Department of Cancer and Surgery, Oslo University Hospital, and Hospice Lovisenberg. Viebe established and ran the Biotech 2010 and 2011 conferences on commercialisation of medical research. The conferences were among the biggest in Northern Europe in their field.
firstname.lastname@example.org – (+47) 91315131
MSc in Business, BI Norwegian Business School
Aarnes is CFO of SEALD. He has broad experience of financial consultancy, particularly on the use of finance functions and financial planning. Aarnes is an MSc in Business (‘siviløkonom’) from BI Norwegian Business School and a state authorised public accountant. He is a senior consultant at Uniconsult AS. His background as CFO of Targovax ASA gives him first-hand experience of taking a research-focused biotechnology company from the early stages of its development all the way to stock exchange listing.
email@example.com – (+47) 93403849
Jonasson has over 25 years of work experience from regulatory authority, pharmaceutical industry and academic research. Specialties: Biomarkers, Drug Discovery & Development, Omics, Pharmacogenetics, Phenotype/Genotype research, Biobanks, Health registers, EMRs, Observational research, Epidemiology & Real World Data, Innovation, Public-Private-Partnerships. Jonasson serves as a working Board Member.
Ove V. Solesvik
Business Development Advisor
Solesvik has more than 30 years of national and international experience with research-, technology- and innovation based business development and management, with main focus on Health and Life Sciences, including medical devices and E-health. He has extensive management experience from both public and private sector.